These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8212155)

  • 41. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 42. Does low-dose allopurinol, with azathioprine, cyclosporin and prednisolone, improve renal transplant immunosuppression?
    Chocair PR; Duley JA; Cameron JS; Arap S; Ianhez L; Sabbaga E; Simmonds HA
    Adv Exp Med Biol; 1994; 370():205-8. PubMed ID: 7660891
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of renal transplant rejection with 15-deoxyspergualin--a dose-finding study in man.
    Ohlman S; Gannedahl G; Tydén G; Tufveson G; Groth CG
    Transplant Proc; 1992 Feb; 24(1):318-20. PubMed ID: 1539294
    [No Abstract]   [Full Text] [Related]  

  • 44. Infectious complications in renal transplant recipients: a 10-year review of cyclosporine-based immunosuppression.
    Tsai MK; Lee PH; Hu RH; Lee CJ
    Transplant Proc; 1998 Nov; 30(7):3125-6. PubMed ID: 9838381
    [No Abstract]   [Full Text] [Related]  

  • 45. High incidence of posttransplant diabetes mellitus in renal transplant recipients on triple-drug immunosuppression.
    Sakhuja V; Sharma UK; Jha V; Minz M; Chugh KS
    Transplant Proc; 1995 Oct; 27(5):2728-30. PubMed ID: 7482892
    [No Abstract]   [Full Text] [Related]  

  • 46. Critical threshold of azathioprine dosage for maintenance immunosuppression in kidney graft recipients. Collaborative Transplant Study.
    Opelz G; Döhler B
    Transplantation; 2000 Mar; 69(5):818-21. PubMed ID: 10755533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclosporine: five years' experience in cadaveric renal transplantation.
    Merion RM; White DJ; Thiru S; Evans DB; Calne RY
    N Engl J Med; 1984 Jan; 310(3):148-54. PubMed ID: 6361559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation.
    Sandrini S; Maiorca R; Scolari F; Cancarini G; Setti G; Gaggia P; Cristinelli L; Zubani R; Bonardelli S; Maffeis R; Portolani N; Nodari F; Giulini SM
    Transplantation; 2000 May; 69(9):1861-7. PubMed ID: 10830223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee.
    Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424
    [No Abstract]   [Full Text] [Related]  

  • 50. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine.
    Aleksic I; Baryalei M; Busch T; Pieske B; Schorn B; Strauch J; Sîrbu H; Dalichau H
    Transplantation; 2000 Apr; 69(8):1586-90. PubMed ID: 10836367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of high lymphocyte sensitivity to glucocorticoids on kidney graft survival in patients treated with azathioprine and cyclosporine.
    Langhoff E; Ladefoged J
    Transplantation; 1987 Mar; 43(3):380-4. PubMed ID: 3547794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients.
    van den Dorpel MA; Levi M; IJzermans JN; ten Cate JW; Weimar W
    Transplant Proc; 1999; 31(1-2):329. PubMed ID: 10083130
    [No Abstract]   [Full Text] [Related]  

  • 53. Analysis of long-term results in kidney transplantation performed using a rejection-free protocol with cyclosporine and thoracic duct drainage.
    Kinukawa T; Ono Y; Takeuchi N; Hattori R; Ohshima S
    Transplant Proc; 1997; 29(1-2):946-7. PubMed ID: 9123600
    [No Abstract]   [Full Text] [Related]  

  • 54. Metabolic effects of a corticosteroid-free immunosuppressive regimen in recipients of pancreatic transplant.
    Luzi L; Picena Sereni L; Battezzati A; Elli A; Soulillou JP; Cantarovich D
    Transplantation; 2003 Jun; 75(12):2018-23. PubMed ID: 12829904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Living-related kidney transplantation using low-dose triple immunosuppression.
    Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
    Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of the safety and efficacy of mycophenolate mofetil, prednisolone and cyclosporine and conventional cyclosporine and prednisolone in kidney transplantation.
    Kim HC; Park SB; Kim HT; Cho WH; Park CH
    Transplant Proc; 2000 Nov; 32(7):1751-2. PubMed ID: 11119919
    [No Abstract]   [Full Text] [Related]  

  • 57. Adult height achieved in children after kidney transplantation.
    Aschendorff C; Offner G; Winkler L; Schirg E; Hoyer PF; Brodehl J
    Am J Dis Child; 1990 Oct; 144(10):1138-41. PubMed ID: 2403096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transfer of patients with kidney grafts to Sandimmun Neoral normalizes the calcium level in erythrocyts.
    Babarykin D; Amerika D; Adamsone I; Valinietse M; Rosental R
    Transplant Proc; 1996 Dec; 28(6):3137. PubMed ID: 8962215
    [No Abstract]   [Full Text] [Related]  

  • 59. The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients.
    Chocair PR; Duley JA; Simmonds HA; Cameron JS
    Transplantation; 1992 May; 53(5):1051-6. PubMed ID: 1585469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients.
    Wahlberg J; Hanås E; Bergström C; Fellström B; Skarp-Orberg I; Frödin L
    Transplant Proc; 1992 Feb; 24(1):311-2. PubMed ID: 1539291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.